Funder
National Natural Science Foundation of China
Clinical Research Plan of SHDC
2022 Shanghai Young Pharmaceutical Talent Ability Enhancement Project
the14th Five Year Plan for Strengthening the Sea of the First Affiliated Hospital of Naval Medical University
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Strohmaier S, Wallisch C, Kammer M, et al. Survival benefit of first single-organ deceased donor kidney transplantation compared with long-term dialysis across ages in transplant-eligible patients with kidney failure. JAMA Netw Open. 2022;5: e2234971.
2. Wojciechowski D, Wiseman A. Long-term immunosuppression management: opportunities and uncertainties. Clin J Am Soc Nephrol. 2021;16:1264–71.
3. Chen L, Yang Y, Wang X, et al. Wuzhi capsule dosage affects tacrolimus elimination in adult kidney transplant recipients, as determined by a population pharmacokinetics analysis. Pharmgenomics Pers Med. 2021;14:1093–106.
4. Broen JCA, van Laar JM. Mycophenolate mofetil, azathioprine and tacrolimus: mechanisms in rheumatology. Nat Rev Rheumatol. 2020;16:167–78.
5. Oberbauer R, Bestard O, Furian L, et al. Optimization of tacrolimus in kidney transplantation: new pharmacokinetic perspectives. Transplant Rev. 2020;34: 100531.